Evidence map›Paper›PMID 38382770›Full record

ArticleAnnals of epidemiology2024

Estimating the mortality risk correcting for high loss to follow-up among female sex workers with HIV in Durban, South Africa, 2018-2021.

Sita Lujintanon, Harry Hausler, Carly Comins, Mfezi Mcingana, Lillian Shipp, Deliwe Rene Phetlhu, Siyanda Makama, Vijayanand Guddera, Sharmistha Mishra, Stefan Baral and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of epidemiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Sita LujintanonDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, United States. Electronic address: slujint1@jhu.edu.
Harry HauslerTB HIV Care, 7th Floor, 11 Adderley St, Cape Town City Centre, Cape Town 8001, South Africa; Department of Family Medicine, School of Medicine, University of Pretoria, 7th Floor, HW Snyman North building, Prinshof Campus, 31 Bophelo Rd, Gezina, Pretoria 0084, South Africa.
Carly CominsDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, United States.
Mfezi McinganaTB HIV Care, Suit No. 2, Sutton Square, 306/310 Mathews Meyiwa Rd, Morningside, Durban 4001, South Africa.
Lillian ShippDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, United States.
Deliwe Rene PhetlhuDepartment of Nursing, Sefako Makgatho Health Sciences University, Molotlegi St, Ga-Rankuwa, Pretoria, Gauteng 0208, South Africa.
Siyanda MakamaTB HIV Care, Suit No. 2, Sutton Square, 306/310 Mathews Meyiwa Rd, Morningside, Durban 4001, South Africa.
Vijayanand GudderaTB HIV Care, Suit No. 2, Sutton Square, 306/310 Mathews Meyiwa Rd, Morningside, Durban 4001, South Africa.
Sharmistha MishraSt. Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, 30 Bond St, Toronto, Ontario, M5B 1W8, Canada.
Stefan BaralDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, United States.
Sheree SchwartzDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, United States.
Johns Hopkins University · USRight to Care · ZACity of Cape Town · ZASefako Makgatho Health Sciences University · ZASt. Michael's Hospital · CA

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Examining PrEP use, implementation preferences and the potential for social support to improve PrEP delivery and persistence among female sex workers in Durban, South AfricaR01NR016650 · NINR · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2016 to 2020
$3.2M
Leveraging Big Data Science to Focus the HIV Response in Countries with Generalized HIV EpidemicsR01AI170249 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2022 to 2025
$2.9M
NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI170249NINR NIH HHS R01 NR016650
6 · The paper itself

Abstract

purposeThis study assesses risk factors of loss to follow-up (LTFU) and estimates mortality risk among female sex workers (FSW) with HIV in Durban, South Africa, in 2018-2021.

methodsWe used data from the Siyaphambili trial, which evaluated strategies for improved viral suppression. FSW with HIV aged ≥ 18 years with viral load ≥ 50 copies/mL were followed up for 18 months. LTFU was defined as absence from study or intervention visits for 6 months. We traced LTFU participants by calling/in-person visit attempts to ascertain their vital status. We used Cox regression to determine risk factors of LTFU and inverse probability of tracing weights to correct mortality risk.

resultsOf 777 participants, 10 (1.3%) had died and 578 (74.4%) were initially LTFU. Among those LTFU, 36.3% (210/578) were traced successfully, with 6 additional deaths ascertained. Recent physical and sexual violence, and non-viral suppression were associated with increased LTFU. The unweighted and weighted 18-month mortality risks were 2.4% (95% CI: 0.8%-3.9%) and 3.7% (95% CI: 1.8%-5.9%), respectively.

conclusionsLTFU is common among FSW with HIV in South Africa with additional investigation of vital status demonstrating under-ascertained mortality. These data suggest the need for comprehensively addressing risks for mortality among FSW.

Indexed as

HIV InfectionsSex WorkersFemaleFollow-Up StudiesHumansLost to Follow-UpSouth AfricaFemale sex workersHIVLoss to follow-upMortalitySouth Africa

Identifiers

PMID38382770
PMCPMC10981924
OpenAlexW4391925466

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.